Immunochina

Updated: March 21, 2026
The team
The team
Country: China | Funding: $45.2M (+)
Founded: 2015

Website: http://www.immunochina.com/

Immunochina provides cancer diagnosis and treatment services based on Chimeric Antigen Receptor T-cell immunotherapy.

Competitors